Home Healthcare Medical Devices Oxygen Therapy Devices Market

Oxygen Therapy Devices Market Size, Share & Trends Analysis Report By Product (Oxygen Source Equipment, Oxygen Delivery Devices), By Application (Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Cystic Fibrosis, Pneumonia, Others), By End Use (Home Healthcare, Non-home Healthcare) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: September 21, 2026 | Author: Debashree Bora | Format:

Oxygen Therapy Devices Market Size

The global oxygen therapy devices market size was valued at USD 39.09 billion in 2025 and is projected to grow from USD 41.69 billion in 2026 to USD 69.84 billion by 2034, registering a CAGR of 6.66% during the forecast period from 2026 to 2034. North America dominated the oxygen therapy devices market with a market share of 38.5% in 2025.

Oxygen therapy devices are medical equipment designed to deliver supplemental oxygen to patients experiencing respiratory disorders or low blood oxygen levels. These devices include oxygen concentrators, cylinders, liquid oxygen systems, masks, and nasal cannulas used in hospitals, clinics, emergency care, and home healthcare settings. Demand is driven by the rising prevalence of chronic respiratory diseases, an aging population, increasing home-based care, and advancements in portable oxygen delivery technologies.

Oxygen Therapy Devices Market Key Takeaways

Global Market Size & Growth

2025 Market Size
USD 39.09 Billion
2026 Market Size
USD 41.69 Billion
2034 Projected Market Size
USD 69.84 Billion
Forecast Period
2026–2034
Base Year
2025
Market CAGR (2026–2034)
6.66%

Regional Insights

Largest Regional Market (2025)
North America
North America Market Share (2025)
38.5%
Fastest-Growing Region
Asia Pacific
Asia Pacific CAGR (2026–2034)
8.9%

Segment Insights

By Product
Leading Segment
Oxygen Source Equipment
Market Share in 2025 68.4%
By Oxygen Source Equipment
Leading Segment
Oxygen Concentrators
Market Share in 2025 39.8%
By Oxygen Cylinders
Leading Segment
Fixed
Market Share in 2025 58.3%
By Oxygen Concentrators
Leading Segment
Fixed
Market Share in 2025 62.6%
Oxygen Therapy Devices Market Size

Download a Free Sample To learn more about this report.

Oxygen Therapy Devices Market Dynamics

01

Rising Prevalence of Chronic Respiratory Diseases

The growing prevalence of chronic respiratory conditions, including chronic obstructive pulmonary disease and other disorders affecting lung function, is increasing demand for oxygen therapy. Many patients require supplemental oxygen to manage reduced blood oxygen levels and support long-term respiratory care. The expanding burden of chronic respiratory diseases therefore provides a fundamental driver for the oxygen therapy devices market.

01

High Cost of Advanced Portable Oxygen Therapy Devices

Advanced portable oxygen concentrators and specialized oxygen delivery systems can involve substantial acquisition and maintenance costs. These affordability challenges may limit access to advanced oxygen therapy devices, particularly among price-sensitive patients and healthcare providers.

01

Expansion of Home Healthcare and Remote Patient Care Services

Healthcare systems are increasingly supporting care models that enable eligible patients to receive treatment and monitoring outside hospitals. This expansion creates demand for reliable oxygen delivery equipment designed for home use and integration with remote care services.

01

Ensuring Safe and Reliable Oxygen Delivery Across Different Care Settings

Oxygen therapy requires appropriate device operation, maintenance, and monitoring to ensure patients receive the prescribed level of oxygen safely. Equipment malfunction, incorrect usage, and inconsistent maintenance can affect treatment reliability. Ensuring device safety, dependable performance, and proper patient education across hospitals, clinics, and home-care environments remains a significant challenge for market participants.

Oxygen Therapy Devices Market Segmentation Analysis

By Product

Oxygen Source Equipment Segment Dominated the Market with 68.4% Share in 2025

The oxygen source equipment segment dominated the global oxygen therapy devices market with a 68.4% share in 2025, driven by the increasing prevalence of chronic respiratory disorders and the growing demand for reliable long-term oxygen therapy. The widespread use of oxygen generation and storage devices across hospitals, emergency care settings, and home healthcare continues to strengthen the segment's leading position.

The oxygen delivery devices segment is witnessing steady growth as healthcare providers increasingly adopt advanced delivery systems to improve patient comfort and treatment efficiency. Rising demand for personalized oxygen therapy, coupled with the growing aging population and increasing incidence of respiratory illnesses, continues to support the expansion of this segment.

Continuous technological advancements in portable oxygen systems, smart monitoring capabilities, and energy-efficient devices are expected to further accelerate market growth. Increasing investments in respiratory care infrastructure and home-based treatment solutions continue to create opportunities across both product categories.

Oxygen Therapy Devices Market Size By Segments

Request Customizationto receive a tailored report.

By Oxygen Source Equipment

Oxygen Concentrators Segment Dominated the Market with 39.8% Share in 2025

The oxygen concentrators segment dominated the oxygen source equipment market with a 39.8% share in 2025, owing to their ability to provide a continuous oxygen supply without frequent refilling. Their ease of use, lower operating costs, and growing adoption in home healthcare settings have made them the preferred choice for long-term oxygen therapy.

The oxygen cylinders and PAP devices segments are witnessing steady growth as healthcare facilities continue to rely on cylinders for emergency oxygen supply while the increasing prevalence of sleep-related breathing disorders is driving demand for PAP devices. At the same time, liquid oxygen devices are gaining wider acceptance among patients requiring high-flow oxygen therapy due to their portability and higher oxygen storage capacity.

Within oxygen cylinders, fixed cylinders continue to account for the larger share because of their extensive use in hospitals and healthcare facilities, while portable cylinders are gaining popularity for ambulatory patients. In oxygen concentrators, fixed units remain widely used for continuous therapy, whereas portable concentrators are expanding rapidly due to their lightweight design and greater patient mobility. Among PAP devices, CPAP continues to lead the segment, while APAP is witnessing faster adoption because of its automatic pressure adjustment capabilities, and Bi-PAP devices remain an important option for patients requiring advanced respiratory support.

By Oxygen Delivery Devices

Nasal Cannula Segment Dominated the Market with 27.4% Share in 2025

The nasal cannula segment dominated the oxygen delivery devices market with a 27.4% share in 2025, driven by its high patient comfort, ease of use, and suitability for long-term oxygen therapy. Its widespread adoption across hospitals, outpatient facilities, and home healthcare continues to support the segment's leading position.

The oxygen masks, Venturi masks, and CPAP masks segments are witnessing steady growth due to increasing demand for controlled oxygen delivery across different clinical conditions. Meanwhile, non-rebreather masks and bag valve masks continue to play an essential role in emergency medicine and critical care, where rapid oxygen administration is required.

The others segment is also expanding steadily as manufacturers introduce specialized oxygen delivery interfaces designed for pediatric care, high-flow oxygen therapy, and patient-specific clinical needs. Ongoing innovations focused on improving patient comfort, oxygen efficiency, and ease of use are expected to support growth across all oxygen delivery device categories.

By Application

Chronic Obstructive Pulmonary Disease Segment Dominated the Market with 34.2% Share in 2025

The chronic obstructive pulmonary disease (COPD) segment dominated the global oxygen therapy devices market with a 34.2% share in 2025, supported by the growing prevalence of chronic respiratory disorders and the increasing need for long-term oxygen therapy. Rising aging populations, smoking-related illnesses, and improved diagnosis rates continue to drive demand for oxygen therapy devices in COPD management.

The obstructive sleep apnea, asthma, and pneumonia segments are witnessing steady growth as awareness of respiratory health increases and more patients receive timely diagnosis and treatment. Growing adoption of PAP devices and home oxygen therapy solutions is contributing significantly to the expansion of these application areas.

The respiratory distress syndrome, cystic fibrosis, and others segments are also growing steadily due to rising demand for specialized respiratory care across neonatal, pediatric, and adult patient populations. Continuous improvements in respiratory support technologies and expanding access to advanced healthcare services are expected to sustain long-term growth across these applications.

By End Use

Home Healthcare Segment Dominated the Market with 61.3% Share in 2025

The home healthcare segment dominated the global oxygen therapy devices market with a 61.3% share in 2025, driven by the increasing preference for home-based treatment among patients with chronic respiratory diseases. Growing availability of portable oxygen therapy devices, reduced hospitalization costs, and improving reimbursement support continue to strengthen demand in this segment.

The non-home healthcare segment is witnessing steady growth as hospitals, specialty clinics, rehabilitation centers, and emergency care facilities continue to invest in advanced respiratory care equipment. Rising hospital admissions related to respiratory illnesses and the need for continuous oxygen support remain key factors supporting this segment.

Increasing healthcare infrastructure development, technological advancements in respiratory devices, and the growing burden of chronic lung diseases are expected to create sustained demand across both home and non-home healthcare settings, supporting the overall expansion of the market.

Oxygen Therapy Devices Market Share By Segments

Speak to an Analystto discuss market opportunities.

Oxygen Therapy Devices Market Regional Outlook

North America Oxygen Therapy Devices Market Analysis

North America oxygen therapy devices market accounted for 38.5% of the global market, reaching USD 15.05 billion in 2025, and is projected to grow at a CAGR of 6.8% during the forecast period. Rising prevalence of chronic respiratory diseases, increasing demand for home healthcare, and growing adoption of portable oxygen delivery systems continue to drive regional market growth. Expanding healthcare infrastructure and favorable reimbursement policies are also supporting market expansion.

United States Oxygen Therapy Devices Market Insights

The U.S. market was valued at USD 12.79 billion in 2025, making it the largest contributor in North America. Growing cases of chronic obstructive pulmonary disease (COPD), increasing aging population, and rising demand for home-based respiratory care continue to strengthen market growth.

Canada Oxygen Therapy Devices Market Insights

Canada's market reached USD 2.26 billion in 2025. Increasing awareness of respiratory health, expanding healthcare services, and growing adoption of advanced oxygen therapy devices continue to support steady market expansion.

North America Oxygen Therapy Devices Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Oxygen Therapy Devices Market Analysis

Europe oxygen therapy devices market accounted for 27.4% of the global market, reaching USD 10.71 billion in 2025, and is expected to register a CAGR of 6.5% during the forecast period. Increasing prevalence of respiratory disorders, rising healthcare expenditure, and growing demand for long-term oxygen therapy are driving regional growth. Continuous investments in advanced medical technologies further support market development.

Germany Oxygen Therapy Devices Market Insights

Germany's market accounted for USD 3.11 billion in 2025. Strong healthcare infrastructure, increasing adoption of home oxygen therapy, and growing elderly population continue to support market growth.

United Kingdom Oxygen Therapy Devices Market Insights

The UK market was valued at USD 2.14 billion in 2025. Rising demand for respiratory care services, expanding home healthcare programs, and increasing healthcare investments continue to contribute to market expansion.

Asia Pacific Oxygen Therapy Devices Market Analysis

Asia Pacific oxygen therapy devices market accounted for 22.8% of the global market, valued at USD 8.91 billion in 2025, and is projected to register a CAGR of 8.9% during the forecast period. Expanding healthcare infrastructure, increasing incidence of respiratory diseases, growing geriatric population, and rising awareness of home healthcare continue to accelerate regional market growth.

Japan Oxygen Therapy Devices Market Insights

Japan's market generated USD 1.60 billion in 2025. Rising demand for respiratory care, increasing adoption of advanced oxygen concentrators, and a growing elderly population continue to support market growth.

China Oxygen Therapy Devices Market Insights

China's market accounted for USD 4.63 billion in 2025, representing the largest share within Asia Pacific. Expanding healthcare facilities, increasing prevalence of chronic respiratory conditions, and growing demand for affordable oxygen therapy devices continue to drive market expansion.

Latin America Oxygen Therapy Devices Market Analysis

Latin America oxygen therapy devices market accounted for 6.1% of the global market, reaching USD 2.38 billion in 2025, and is projected to grow at a CAGR of 7.1% during the forecast period. Improving healthcare infrastructure, increasing awareness of respiratory disease management, and rising demand for home healthcare equipment continue to support regional market growth.

Brazil Oxygen Therapy Devices Market Insights

Brazil's market reached USD 1.21 billion in 2025. Growing healthcare investments, expanding access to respiratory care, and increasing adoption of oxygen therapy devices continue to create growth opportunities across the country.

Middle East & Africa Oxygen Therapy Devices Market Analysis

Middle East & Africa oxygen therapy devices market accounted for 5.2% of the global market, totaling USD 2.03 billion in 2025, and is anticipated to grow at a CAGR of 6.9% during the forecast period. Rising healthcare investments, increasing prevalence of respiratory diseases, and expanding hospital infrastructure are supporting regional market growth.

UAE Oxygen Therapy Devices Market Insights

The UAE market was valued at USD 0.73 billion in 2025. Government investments in advanced healthcare infrastructure, increasing demand for respiratory care solutions, and growing adoption of home oxygen therapy continue to drive market growth.

List of Key and Emerging Players in Oxygen Therapy Devices Market

Ventec Life Systems, Inc.
Unitaid
VARON
MedAccess
Inogen, Inc.
ICU Medical
ResMed
HERSILL S.L.
OMRON Healthcare
GE Healthcare
Fisher & Paykel Healthcare Limited
Respironics
Tecno-Gaz Industries
Teleflex Incorporated
Chart Industries
DeVilbiss Healthcare
Drägerwerk AG & Co. KGaA
Linde
Caire Medical
Rhythm Healthcare
Laboratory Informatics Market

Key Industry Developments

March 2026
Philips expanded its respiratory care portfolio with advanced oxygen therapy solutions designed to improve home-based respiratory support and patient monitoring capabilities.
September 2025
ResMed introduced enhanced respiratory care technologies integrating digital monitoring features to support oxygen therapy management and improve patient outcomes.
May 2025
Invacare expanded its oxygen therapy device portfolio with new portable oxygen concentrator solutions designed to improve mobility and convenience for respiratory care patients.

Report Scope

Segmentation

By Product 2
  • Oxygen Source Equipment
  • Oxygen Delivery Devices
By Application 7
  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Obstructive Sleep Apnea
  • Respiratory Distress Syndrome
  • Cystic Fibrosis
  • Pneumonia
  • Others
By End Use 2
  • Home Healthcare
  • Non-home Healthcare

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 8
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Singapore
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Ventec Life Systems, Inc. · Unitaid · VARON · MedAccess · Inogen, Inc.
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The oxygen therapy devices market size is valued at USD 41.69 Billion in 2026 and is projected to reach USD 69.84 Billion by 2034, at a CAGR of 6.66% during the forecast period 2026-2034.

North America dominated the market with a share of 38.5% in 2025.

The leading players in this market are Ventec Life Systems, Inc., Unitaid, VARON, MedAccess.

The oxygen therapy devices market is projected to grow at a CAGR of 6.66% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: